KPV (Lys-Pro-Val) is an experimental tripeptide derived from α-MSH studied in the laboratory for its role in inflammatory modulation and tissue protection.
Primarily used in research to explore mechanisms related to skin balance, cell recovery, and support of tissues exposed to physiological stress.
Composition
KPV — 5 mg per vial (lyophilized form)
Experimental exhibition
• Quantities studied: 100–500 mcg in preclinical research
• Exploration of cellular anti-inflammatory pathways
• Analysis of local tissue responses
• Studies conducted in controlled environments
Informative benefits
• Studied for inflammatory modulation
• Research on skin balance
• Observation of cellular protection
• Exploration of tissue recovery
• Analysis of local regeneration mechanisms
For research use only – Not intended for human consumption.
